Impact of prior docetaxel (D) on sipuleucel-T (sip-T) product parameters in PROCEED patients (pts).
Year: 2013
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Celestia S. Higano, Andrew J. Armstrong, Matthew R. Cooperberg, Philip W. Kantoff, James Bailen, Raoul S. Concepcion, Vahan Kassabian, Shaker R. Dakhil, Steven E. Finkelstein, Jeffrey L. Vacirca, Robert M. Rifkin, Andrew Sandler, Candice McCoy, James Boyd Whitmore, Robert Claude Tyler, A. Oliver Sartor
Institutions: Seattle Cancer Care Alliance, University of Washington, Duke University, Duke Cancer Institute, University of California, San Francisco, Dana-Farber Cancer Institute, Urology Associates, Georgia Urology, Cancer Center of Kansas, 21st Century Oncology (United States), Rocky Mountain Cancer Centers, Dendreon (United States), Tulane University
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2599036858